TITLE

Hypertension

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS36
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `G-protein receptor kinase-2 is increased with hypertension,' by Robert Gros, Jeffrey L. Benovic et al from the University of Western Ontario.
ACCESSION #
9708236211

 

Related Articles

  • G proteins and hypertension: An alternative candidate gene approach. Siffert, Winfried // Kidney International;Jun1998, Vol. 53 Issue 6, p1466 

    G proteins and hypertension: An alternative candidate gene approach. Hypertension affects approximately 20 to 30% of individuals in industrialized countries, and is commonly believed to develop on the basis of both genetic and environmental factors. The identification of genes susceptibile to...

  • Dopamine Receptor and Hypertension. Zeng, Chunyu; Eisner, Gilbert M.; Felder, Robin A.; Jose, Pedro A. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Jan2005, Vol. 3 Issue 1, p69 

    Dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport and reactive oxygen and by interacting with vasopressin, renin-angiotensin, and the sympathetic nervous system. Decreased renal dopamine production and / or impaired dopamine receptor...

  • Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Tang, Mary; Guang Wang; Ping Lu; Karas, Richard H.; Aronovitz, Mark; Heximer, Scott P.; Kaltenbronn, Kevin M.; Blumer, Kendall J.; Siderovski, David P.; Yan Zhu; Mendelson, Michael E. // Nature Medicine;Dec2003, Vol. 9 Issue 12, p1506 

    Nitric oxide (NO) inhibits vascular contraction by activating cGMP-dependent protein kinase I-a (PKGI-a), which causes dephosphorylation of myosin light chain (MLC) and vascular smooth muscle relaxation. Here we show that PKGI-a attenuates signaling by the thrombin receptor protease-activated...

  • Distinct Roles of Central and Peripheral Prostaglandin E2 and EP Subtypes in Blood Pressure Regulation. Yang, Tianxin; Du, Yaomin // American Journal of Hypertension;Oct2012, Vol. 25 Issue 10, p1042 

    Prostaglandin E2 (PGE2) is a major prostanoid with a wide variety of biological activities. PGE2 can influence blood pressure (BP) both positively and negatively. In particular, centrally administered PGE2 induces hypertension whereas systemic administration of PGE2 produces a hypotensive...

  • G12-G13—LARG—mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Wirth, Angela; Benyó, Zoltán; Lukasova, Martina; Leutgeb, Barbara; Wettschureck, Nina; Gorbey, Stefan; Örsy, Petra; Horváth, Béla; Maser-Gluth, Christiane; Greiner, Erich; Lemmer, Björn; Schütz, Günther; Gutkind, Silvio; Offermanns, Stefan // Nature Medicine;Jan2008, Vol. 14 Issue 1, p64 

    The tone of vascular smooth muscle cells is a primary determinant of the total peripheral vascular resistance and hence the arterial blood pressure. Most forms of hypertension ultimately result from an increased vascular tone that leads to an elevated total peripheral resistance. Regulation of...

  • RGS2: a "turn-off" in hypertension. Le, Thu H.; Coffman, Thomas M. // Journal of Clinical Investigation;2/15/2003, Vol. 111 Issue 4, p441 

    Discusses the function of regulators of G protein signaling (RGS2) in the regulation of blood pressure and vascular structure. Roles of RGS2 in cardiovascular regulation; Potential role of chronic vasoconstriction in hypertension; Relationship between RGS2 and angiotensin II type 1 receptor.

  • Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. Heximer, Scott P.; Knutsen, Russell H.; Xiaoguang Sun; Kaltenbronn, Kevin M.; Man-Hee Rhee; Ning Peng; Oliviera-dos-Santos, Antonio; Penninger, Josef M.; Muslin, Anthony J.; Steinberg, Thomas H.; Wyss, J. Michael; Mecham, Robert P.; Blumer, Kendall J. // Journal of Clinical Investigation;2/15/2003, Vol. 111 Issue 4, p445 

    Presents a study which examined hypertension and prolonged vasoconstrictor signaling in regulators of G protein signaling (RGS2)-deficient mice. Methods; Results; Discussion and conclusion.

  • Angiotensin II Receptor Blocker as an Inverse Agonist: A Current Perspective. Miura, Shin-ichiro; Fujino, Masahiro; Saku, Keijiro // Current Hypertension Reviews;2005, Vol. 1 Issue 2, p115 

    Angiotensin II (Ang II) receptor blockers (ARBs) are highly selective for the Ang II type 1 receptor (AT1), which is a member of the G protein-coupled receptor superfamily (GPCRs), and block the diverse effects of the agonist Ang II. Many studies have shown that these agents are safe and...

  • GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats. Nagareddy, Prabhakara Reddy; MacLeod, Kathleen M.; McNeill, John H. // Cardiovascular Research;Jul2010, Vol. 87 Issue 1, p177 

    Aims: The presence of metabolic abnormalities such as insulin resistance and elevated levels of various vasoconstrictor G-protein-coupled receptor (GPCR) agonists contributes to the development of hypertension. Recent studies have suggested a link between disease progression and activation of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics